Can PSMA-Targeting Radiopharmaceuticals Be Useful for Detecting Hepatocellular Carcinoma Using Positron Emission Tomography? An Updated Systematic Review and Meta-Analysis

Background: Several studies proposed the use of positron emission tomography (PET) with Prostate-Specific Membrane Antigen (PSMA)-targeting radiopharmaceuticals in hepatocellular carcinoma (HCC). Our aim is to calculate the detection rate (DR) of this examination in HCC with a meta-analysis. Methods...

Descripción completa

Detalles Bibliográficos
Autores principales: Rizzo, Alessio, Racca, Manuela, Albano, Domenico, Dondi, Francesco, Bertagna, Francesco, Annunziata, Salvatore, Treglia, Giorgio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9699564/
https://www.ncbi.nlm.nih.gov/pubmed/36355540
http://dx.doi.org/10.3390/ph15111368

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9699564/
https://www.ncbi.nlm.nih.gov/pubmed/36355540
http://dx.doi.org/10.3390/ph15111368

Ejemplares similares